InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Thompson Juliet, Director. Insider active across 2 companies, notably Indivior Pharmaceuticals, Inc.. In total, 2 disclosures have been recorded. History available since 12 May 2026. The latest transaction was filed on 12 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Juliet Thompson is a Director at Indivior Pharmaceuticals, Inc. She contributes to the governance of the company and strategic decision-making. Her experience in the pharmaceutical sector is an asset to the board of directors. She plays a key role in the future direction of Indivior.